2015 annual financial data
Halozyme Therapeutics 2015 Revenue growth
Direct answer
Revenue growth was 79.28%.
Operating income was -27,452,000 USD and net income was -32,231,000 USD.
Operating cash flow was -37,083,000 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 135,057,000 USD
- Operating income
- -27,452,000 USD
- Net income
- -32,231,000 USD
- Operating cash flow
- -37,083,000 USD